Preclinical toxicology of ifosfamide
Barnett, D.
Seminars in Oncology 9(4 Suppl 1: 8-13
1982
ISSN/ISBN: 0093-7754 PMID: 6761867 Document Number: 196569
Document emailed within 1 workday
Related Documents
Tucker, W.E. 1983: Preclinical toxicology of bupropion: an overview Journal of Clinical Psychiatry 44(5 Part 2): 60-62Martin, R.A.; de la Iglesia, F.A. 1988: Preclinical toxicology of pirmenol hydrochloride Angiology 39(3 Part 2): 299-306
Smith, A.C.; Barrett, D.; Stedham, M.A.; el-Hawari, M.; Kastello, M.D.; Grieshaber, C.K.; Boyd, M.R. 1987: Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer Cancer Treatment Reports 71(12): 1157-1164
Collery, P.; Domingo, J.L.; Keppler, B.K. 1996: Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III) Anticancer Research 16(2): 687-691
Ishimatsu, S. 2016: Translational toxicology from basic sciences to clinical toxicology Sequelae of victims in Tokyo subway sarin attack Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 29(3): 264-267
Fujita, Y. 2015: Practical analysis of toxic substances useful for clinical toxicology: From sample preparation to screening. Announcement from the Committee on Toxicology Laboratories Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 28(3): 265
Sanotskiĭ, I.V.; Nikitenko, T.K. 1981: Soviet toxicology center of the International Registry of Potentially Toxic Chemical Substances, a coordinating link in the system of preventive toxicology institutions Gigiena i Sanitariia 1981(1): 93-94
Locket, S. 1973: Toxicology. I. Clinical toxicology: some facts and figures Practitioner 210(255): 165-170
Suzuki, O. 2000: From medicolegal toxicology to forensic toxicology Nihon Hoigaku Zasshi 54(3): 330-344
Matrka, M. 1991: Industrial toxicology and ecological toxicology Casopis Lekaru Ceskych 130(1): 1-6
Schoenike, S.E.; Dana, W.J. 1990: Ifosfamide and mesna Clinical Pharmacy 9(3): 179-191
Springate, J.; Zamlauski-Tucker, M.J.; Lu, H.; Chan, K.K. 1997: Renal clearance of ifosfamide Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(9): 1081-1082
Loehrer, P.J. 1990: Ifosfamide in testicular cancer Seminars in Oncology 17(2 Suppl 4: 2-5
Goldsmith, K. 1991: Ifosfamide administration recommendation questioned Oncology Nursing Forum 18(3): 476
Colvin, M. 1982: The comparative pharmacology of cyclophosphamide and ifosfamide Seminars in Oncology 9(4 Suppl 1: 2-7
Holoye, P.Y.; Anderson, T.; Duelge, J.; Hansen, R.M.; Ritch, P.S. 1982: Use and safety of high-dose ifosfamide Seminars in Oncology 9(4 Suppl 1: 78-86
Goldin, A. 1982: Ifosfamide in experimental tumor systems Seminars in Oncology 9(4 Suppl 1: 14-23
Blaschke, G.; Widey, W. 1989: Metabolism of enantiomers of the cytostatic ifosfamide Arzneimittel-Forschung 39(2): 223-226
Von Ardenne, M.; Reitnauer, P.G. 1975: Treatment of the DS-carcinosarcoma in the rat with ifosfamide/dimethylsulfoxide Die Pharmazie 30(9): 602-605
Holoye, P.Y.; Duelge, J.; Hansen, R.M.; Ritch, P.S.; Anderson, T. 1983: Prophylaxis of ifosfamide toxicity with oral acetylcysteine Seminars in Oncology 10(1 Suppl 1: 66-71